Business, energy, technology, markets and global industry news from Business News Today

HanchorBio

PharmaDeviceNews HanchorBio
Editorial infographic showing Oncomatryx’s OMTX305 in a tumor microenvironment, with immune T cells attacking cancer tissue and tumor-supporting fibroblasts, highlighting preclinical anti-tumor activity and unresolved clinical translation questions.
Pharma & Biotech

Can Oncomatryx OMTX305 overcome immune resistance in solid tumors?

Oncomatryx OMTX305 activates T cells and destroys tumor-supporting fibroblasts in preclinical cancer models. Examine the findings and limitations.

Read More
HanchorBio’s collaboration with Taiwan Cancer Moonshot researchers aims to combine multi-omics cancer data with biomarker-driven precision oncology and immunotherapy development, including research relevant to its HCB101 pipeline. Representative image.
Pharma & Biotech

HanchorBio wants biomarkers to sharpen its cancer pipeline. Can Taiwan Cancer Moonshot data deliver?

HanchorBio teams with Taiwan Cancer Moonshot researchers to add multi-omics and biomarker depth to its precision immunotherapy strategy.

Read More